Fidelity Investments’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21M Buy
9,238,868
+9,130,557
+8,430% +$20.7M ﹤0.01% 1680
2025
Q1
$68.9K Sell
108,311
-198,472
-65% -$126K ﹤0.01% 3715
2024
Q4
$316K Buy
306,783
+22,476
+8% +$23.2K ﹤0.01% 3085
2024
Q3
$335K Buy
284,307
+41,949
+17% +$49.5K ﹤0.01% 3005
2024
Q2
$296K Buy
242,358
+59,281
+32% +$72.3K ﹤0.01% 2899
2024
Q1
$399K Sell
183,077
-382,247
-68% -$833K ﹤0.01% 2800
2023
Q4
$876K Sell
565,324
-142,644
-20% -$221K ﹤0.01% 2512
2023
Q3
$913K Sell
707,968
-19,412
-3% -$25K ﹤0.01% 2475
2023
Q2
$1.25M Buy
727,380
+21,683
+3% +$37.3K ﹤0.01% 2438
2023
Q1
$1.07M Sell
705,697
-10,949
-2% -$16.5K ﹤0.01% 2510
2022
Q4
$1.15M Buy
716,646
+15,074
+2% +$24.1K ﹤0.01% 2505
2022
Q3
$1.02M Sell
701,572
-1,637
-0.2% -$2.37K ﹤0.01% 2605
2022
Q2
$1.29M Buy
703,209
+1,392
+0.2% +$2.55K ﹤0.01% 2615
2022
Q1
$1.87M Buy
701,817
+165,382
+31% +$442K ﹤0.01% 2629
2021
Q4
$2.32M Sell
536,435
-509,185
-49% -$2.2M ﹤0.01% 2532
2021
Q3
$5.32M Hold
1,045,620
﹤0.01% 2348
2021
Q2
$6.62M Buy
1,045,620
+13
+0% +$82 ﹤0.01% 2251
2021
Q1
$8.08M Hold
1,045,607
﹤0.01% 2110
2020
Q4
$6.85M Buy
1,045,607
+220,700
+27% +$1.45M ﹤0.01% 2099
2020
Q3
$5.49M Sell
824,907
-4,066
-0.5% -$27K ﹤0.01% 2039
2020
Q2
$6.91M Buy
828,973
+360
+0% +$3K ﹤0.01% 1947
2020
Q1
$6.36M Sell
828,613
-5
-0% -$38 ﹤0.01% 1848
2019
Q4
$6.89M Sell
828,618
-56,108
-6% -$466K ﹤0.01% 1970
2019
Q3
$6.53M Sell
884,726
-438,485
-33% -$3.24M ﹤0.01% 1969
2019
Q2
$14.8M Sell
1,323,211
-815,568
-38% -$9.15M ﹤0.01% 1739
2019
Q1
$23M Sell
2,138,779
-3,785,652
-64% -$40.7M ﹤0.01% 1548
2018
Q4
$89.5M Sell
5,924,431
-820,122
-12% -$12.4M 0.01% 902
2018
Q3
$125M Buy
6,744,553
+900,927
+15% +$16.7M 0.01% 859
2018
Q2
$134M Buy
5,843,626
+51,953
+0.9% +$1.19M 0.02% 819
2018
Q1
$165M Buy
5,791,673
+30,379
+0.5% +$864K 0.02% 762
2017
Q4
$122M Buy
5,761,294
+231,189
+4% +$4.88M 0.01% 906
2017
Q3
$100M Buy
5,530,105
+17,646
+0.3% +$321K 0.01% 974
2017
Q2
$85.4M Buy
5,512,459
+34,732
+0.6% +$538K 0.01% 1058
2017
Q1
$94.6M Buy
5,477,727
+17,375
+0.3% +$300K 0.01% 1014
2016
Q4
$60M Buy
5,460,352
+17,090
+0.3% +$188K 0.01% 1213
2016
Q3
$85.4M Buy
5,443,262
+30,097
+0.6% +$472K 0.01% 1052
2016
Q2
$55.3M Buy
5,413,165
+1,484
+0% +$15.2K 0.01% 1233
2016
Q1
$69.8M Buy
5,411,681
+8,038
+0.1% +$104K 0.01% 1118
2015
Q4
$113M Buy
+5,403,643
New +$113M 0.02% 918